MedGenome Partners with Green Cross to Broaden Genomics Access

MedGenome, a leading global genomics-based diagnostics and research company, has made a majority investment in Gujarat-headquartered Green Cross Genetics Lab, strengthening its footprint in India’s growing diagnostics market.

With over 30 years of trust and quality, Green Cross operates 17 modern laboratories and 35 collection centres across Gujarat. Each facility runs under the supervision of senior medical professionals, maintaining high standards of accuracy and reliability.

Also Read: The Future of Genomic Sequencing: Trends That Will Define the Next Decade

The collaboration brings together MedGenome’s genomics expertise and Green Cross’s strong diagnostic network to make advanced and affordable testing more accessible. MedGenome runs South Asia’s largest CAP-accredited multiomics laboratory and uses data-driven analysis to help clinicians identify and treat complex diseases.

Dr. Vedam Ramprasad, CEO of MedGenome, said, “This partnership will strengthen our market presence in Gujarat, allowing us to better serve a broader population. It reiterates our commitment to improving access to affordable omics solutions, particularly in Tier 2 and Tier 3 cities. With Green Cross’s three-decade legacy of trust and high-quality diagnostics, this partnership perfectly aligns with our mission to harness genomics for early, accurate disease detection and management.”

Vinod Patel, promoter and director of Green Cross Genetics Lab, said, “We partner with MedGenome, a leader in genomic testing, to expand our diagnostics service offerings. Our companies have a rich legacy of trust and quality, and this partnership will combine our strengths across infrastructure, technology, distribution, and clinical expertise.”